A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants with Congenital Adrenal Hyperplasia Including a Long-Term Extension

  • Brown, Justin (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date29/01/26 → 28/01/31

Clinical Trial Phase

  • Phase II
  • Phase III (a & b)